[1]
Süleyman Sayar et al. 2020. Risk of hepatitis B reactivation during anti-TNF therapy; evaluation of patients with past hepatitis B infection. Turkish Journal of Gastroenterology. 31, 7 (Apr. 2020), 522–528.